Pharma news
Americas
Supernus Pharmaceuticals has defeated Actavis in a patent infringement dispute centring on epilepsy drug Oxtellar XR. 8 February 2016
Americas
A man who sold and imported counterfeit drugs, including Viagra and Diazepam, into the US has appeared in court. 8 February 2016
Asia
India-based vaccines and biotherapeutic manufacturer Bharat Biotech has said it has filed the first patent for a vaccine for the Zika virus. 5 February 2016
Americas
AstraZeneca has predicted a dip in revenue this year after it loses patent exclusivity on its anti-cholesterol drug Crestor. 4 February 2016
Pharma
The Pharmaq v Intervet SPC decision leaves open the question of just how similar to the authorised active ingredient an infringing generic product needs to be. Sam Bailey of Mewburn Ellis reports. 4 February 2016
Africa
Drugs made by pharmaceutical companies including Abbvie, Gilead, and Merck are set to achieve “blockbuster” status by 2020, according to a report. 3 February 2016
Americas
India-based Sun Pharmaceutical has launched its generic version of Novartis’s cancer treatment drug Gleevec in the US. 2 February 2016
Americas
The Patent Trial and Appeal Board has rejected generics company Lannett Holdings’s petition for an inter partes review because it was filed one day too late. 29 January 2016
Americas
PDL BioPharma has sued Merck Sharp & Dohme in a complaint that centres on a now-expired patent directed to treating melanoma. 28 January 2016
Americas
As reflected in numerous recent court opinions, the broad Supreme Court rulings of Mayo, Myriad and Alice have drastically changed the landscape of patent-eligibility in diagnostics. Jenny Shmuel and Megan Chacon of Fish & Richardson review the situation and discuss some future scenarios. 27 January 2016